Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $11.1 million.

  • Pediatrix Medical's Deferred Taxes rose 2172.06% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year increase of 27817.05%. This contributed to the annual value of -$2.1 million for FY2024, which is 16576.1% down from last year.
  • Latest data reveals that Pediatrix Medical reported Deferred Taxes of $11.1 million as of Q3 2025, which was up 2172.06% from $12.1 million recorded in Q2 2025.
  • Pediatrix Medical's Deferred Taxes' 5-year high stood at $13.8 million during Q4 2024, with a 5-year trough of -$25.7 million in Q2 2024.
  • In the last 5 years, Pediatrix Medical's Deferred Taxes had a median value of $686000.0 in 2024 and averaged -$1.3 million.
  • As far as peak fluctuations go, Pediatrix Medical's Deferred Taxes crashed by 124246.18% in 2022, and later skyrocketed by 54110.79% in 2025.
  • Quarter analysis of 5 years shows Pediatrix Medical's Deferred Taxes stood at -$1.0 million in 2021, then tumbled by 1242.46% to -$14.1 million in 2022, then skyrocketed by 47.76% to -$7.4 million in 2023, then soared by 287.07% to $13.8 million in 2024, then fell by 19.02% to $11.1 million in 2025.
  • Its Deferred Taxes stands at $11.1 million for Q3 2025, versus $12.1 million for Q2 2025 and $4.4 million for Q1 2025.